BIIB vs CWAN · P/E 21, rev $9.89B vs P/E 13, rev $451.8M
Biogen Inc (BIIB) versus Clearwater Analytics Holdings Inc (CWAN) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Clearwater Analytics Holdings Inc (CWAN) is a software - application company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CWAN revenue for 2024-12-31 was $451.8M. Net income was $427.6M. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. CWAN currently screens at market cap $6.34B and trailing P/E 13.2.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CWAN currently screens at market cap $6.34B and trailing P/E 13.2.
Not investment advice. Open the BIIB and CWAN stock pages for the full models.
Not investment advice.